Last edition
News about "non-surgical subcutaneous fat reduction "
Caliway Reports Positive Phase 2 Results in Dercum's Disease
Caliway Biopharmaceuticals has reported final Phase 2 results showing sustained pain reduction with CBL-514 in patients with Dercum’s disease.
Non-surgical Subcutaneous Fat Reduction | 24/09/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members